Skip to main content
Premium Trial:

Request an Annual Quote

LLNL and Uppsala University Sequence Tularemia Genome

NEW YORK, Feb. 27 (GenomeWeb News) - The US Department of Energy's Lawrence Livermore National Laboratory and Uppsala University of Uppsala, Sweden have collaborated to sequence two strains of Francisella tularensis, a bacterium that causes tularemia, or rabbit fever, the two groups said yesterday.


F. tularensis is thought to be a potential bioterror agent.


The SchuS4 strain that UU sequenced is more virulent and is found primarily in North America, while the LVL strain that LLNL sequenced is less virulent but more widespread. The SchuS4 sequence is available here. The LVS sequence is being published here. Both sequences will also be submitted to Genbank once they are fully annotated.


The LLNL project was funded by the DOE and other USagencies. The European-American consortium was funded by the US Army Medical Research and Material Command, the UK Ministry of Defense, the Swedish Ministry of Defense, and the US Defense Advanced Research Projects Agency.



The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.